The effect of liraglutide on cardiac autonomic function in type 2 diabetes: A prespecified secondary analysis from the LIRAFLAME randomized, double-blinded, placebo-controlled trial

Suvanjaa Sivalingam; Emilie Hein Zobel; Christian S Hansen; Rasmus S Ripa; Bernt J von Scholten; Viktor Rotbain Curovic; Andreas Kjaer; Jacob K Jensen; Tine W Hansen; Peter Rossing

doi:10.1111/dom.14717

The effect of liraglutide on cardiac autonomic function in type 2 diabetes: A prespecified secondary analysis from the LIRAFLAME randomized, double-blinded, placebo-controlled trial

Suvanjaa Sivalingam^*, Emilie Hein Zobel, Christian S Hansen, Rasmus S Ripa, Bernt J von Scholten, Viktor Rotbain Curovic, Andreas Kjaer, Jacob K Jensen, Tine W Hansen, Peter Rossing

^*Corresponding author af dette arbejde

1 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Diabetes, Obesity and Metabolism
Vol/bind	24
Udgave nummer	8
Sider (fra-til)	1638-1642
Antal sider	5
ISSN	1462-8902
DOI	https://doi.org/10.1111/dom.14717
Status	Udgivet - aug. 2022

Adgang til dokumentet

10.1111/dom.14717

Andre filer og links

Link to publication in Scopus

Citationsformater

Sivalingam, S., Hein Zobel, E., Hansen, C. S., Ripa, R. S., von Scholten, B. J., Rotbain Curovic, V., Kjaer, A., Jensen, J. K., Hansen, T. W., & Rossing, P. (2022). The effect of liraglutide on cardiac autonomic function in type 2 diabetes: A prespecified secondary analysis from the LIRAFLAME randomized, double-blinded, placebo-controlled trial. Diabetes, Obesity and Metabolism, 24(8), 1638-1642. https://doi.org/10.1111/dom.14717

The effect of liraglutide on cardiac autonomic function in type 2 diabetes : A prespecified secondary analysis from the LIRAFLAME randomized, double-blinded, placebo-controlled trial. / Sivalingam, Suvanjaa; Hein Zobel, Emilie; Hansen, Christian S et al.

I: Diabetes, Obesity and Metabolism, Bind 24, Nr. 8, 08.2022, s. 1638-1642.

Publikation: Bidrag til tidsskrift › Letter › peer review

Sivalingam, S, Hein Zobel, E, Hansen, CS , Ripa, RS , von Scholten, BJ , Rotbain Curovic, V , Kjaer, A , Jensen, JK , Hansen, TW & Rossing, P 2022, 'The effect of liraglutide on cardiac autonomic function in type 2 diabetes: A prespecified secondary analysis from the LIRAFLAME randomized, double-blinded, placebo-controlled trial', Diabetes, Obesity and Metabolism, bind 24, nr. 8, s. 1638-1642. https://doi.org/10.1111/dom.14717

@article{cc21434c1b50497fbc3ca00f5a38662d,

title = "The effect of liraglutide on cardiac autonomic function in type 2 diabetes: A prespecified secondary analysis from the LIRAFLAME randomized, double-blinded, placebo-controlled trial",

keywords = "Diabetes Mellitus, Type 2/complications, Double-Blind Method, Humans, Hypoglycemic Agents/pharmacology, Liraglutide/pharmacology, Stroke Volume, Treatment Outcome",

author = "Suvanjaa Sivalingam and {Hein Zobel}, Emilie and Hansen, {Christian S} and Ripa, {Rasmus S} and {von Scholten}, {Bernt J} and {Rotbain Curovic}, Viktor and Andreas Kjaer and Jensen, {Jacob K} and Hansen, {Tine W} and Peter Rossing",

year = "2022",

month = aug,

doi = "10.1111/dom.14717",

language = "English",

volume = "24",

pages = "1638--1642",

journal = "Diabetes, Obesity and Metabolism",

issn = "1462-8902",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "8",

}

TY - JOUR

T1 - The effect of liraglutide on cardiac autonomic function in type 2 diabetes

T2 - A prespecified secondary analysis from the LIRAFLAME randomized, double-blinded, placebo-controlled trial

AU - Sivalingam, Suvanjaa

AU - Hein Zobel, Emilie

AU - Hansen, Christian S

AU - Ripa, Rasmus S

AU - von Scholten, Bernt J

AU - Rotbain Curovic, Viktor

AU - Kjaer, Andreas

AU - Jensen, Jacob K

AU - Hansen, Tine W

AU - Rossing, Peter

PY - 2022/8

Y1 - 2022/8

KW - Diabetes Mellitus, Type 2/complications

KW - Double-Blind Method

KW - Humans

KW - Hypoglycemic Agents/pharmacology

KW - Liraglutide/pharmacology

KW - Stroke Volume

KW - Treatment Outcome

UR - http://www.scopus.com/inward/record.url?scp=85129817475&partnerID=8YFLogxK

U2 - 10.1111/dom.14717

DO - 10.1111/dom.14717

M3 - Letter

C2 - 35415938

VL - 24

SP - 1638

EP - 1642

JO - Diabetes, Obesity and Metabolism

JF - Diabetes, Obesity and Metabolism

SN - 1462-8902

IS - 8

ER -